PA-FPR-22-001: Title X Family Planning Research Grants
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Office of the Assistant Secretary for Health notices from 2022.
Office of the Assistant Secretary for Health offered grants of up to $750,000 (at least $200,000) to the applicants described in the notice. It expected to make about 10 awards. Applications closed on May 24, 2022.
From the official notice on Grants.gov, last changed March 15, 2022. Checked November 7, 2026.
- Award ceiling$750,000
- Award floor$200,000
- Expected awards10
- Cost sharingNot required
- Funding typeGrant
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| PA-FPR-26-001 | June 17, 2026 | Closed July 17, 2026 | Closed |
Key dates
| Posted | March 15, 2022 |
|---|---|
| Deadline | May 24, 2022 |
| Archived by Grants.gov | June 23, 2022 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Any public or private nonprofit entity located in any one of the 50 United States, the District of Columbia, Commonwealth of Puerto Rico, U.S. Virgin Islands, Commonwealth of the Northern Mariana Islands, American Samoa, Guam, Republic of Palau, Federated States of Micronesia, and the Republic of the Marshall Islands is eligible to apply for a grant under this announcement. Faith-based organizations and American Indian/Alaskan Native/Native American (AI/AN/NA) organizations that are public or non-profit private entities are eligible to apply. Community based organizations that are public or non-profit private entities are eligible to apply. Examples of eligible Organizations include: • State Governments • U.S. territories • County Governments • City or township governments • Special district governments • Independent school districts • Public and State controlled institutions of higher education • Native American tribal governments (Federally recognized) • Public Housing authorities/Indian housing authorities • Native American tribal organizations (other than federally recognized tribal governments) • Nonprofits having 501(c)(3) status with the IRS, other than institutions of higher education • Nonprofits without 501(c)(3) status with the IRS, other than institutions of higher education • Private institutions of higher education
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The Office of the Assistant Secretary for Health (OASH), Office of Population Affairs announces the anticipated availability of funds for Fiscal Year (FY) 2022 under the authority of Title X of the Public Health Service Act, Section 1004 (42 U.S.C. 300a-2). The primary focus of OASH is leading America to healthier lives, especially for those who are most vulnerable, including those who have suffered historic disparities. In support of this vision, the Office of Population Affairs (OPA) promotes health across the reproductive lifespan through innovative, evidence-based adolescent health and family planning programs, services, strategic partnerships, evaluation, and research. OPA prioritizes advancing equity for all, including people of color and others who are in need of family planning and sexual and reproductive health services, and are uninsured or underinsured. OPA administers the Title X family planning services program, the Teen Pregnancy Prevention (TPP) Program, and the Embryo Adoption Awareness (EAA) program. OPA advises the Secretary of HHS and the Assistant Secretary for Health on a wide range of topics, including adolescent health, family planning, sterilization, and other population issues. We invite applications from public or private nonprofit entities to conduct research or analyses that will lead to feasible and effective strategies to increase equitable access to quality Title X family planning services among clients in need of family planning and sexual and reproductive health services. Priority areas for these research grants are: • Innovative Strategies to Increase Equitable Access • Impact of Telehealth on Title X Services • Trends and Current Reach of Family Planning Clinics • Trends in Client Need and Use of Title X Services You may select more than one priority area to address in your application, however you must clearly identify the priority area(s) addressed as described in Section F.3.a. Innovative ideas are encouraged for all priority areas, but research leading to feasible, wide-scale, effective interventions is of primary importance.
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is PA-FPR-22-001 still open?
No. It closed on May 24, 2022.
Who can apply for Title X Family Planning Research Grants?
Office of the Assistant Secretary for Health accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Title X Family Planning Research Grants?
Closed May 24, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $750,000 each.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)